The largest database of trusted experimental protocols

Mtt proliferation assay

Manufactured by Merck Group
Sourced in United States

The MTT proliferation assay is a colorimetric assay used to measure cell metabolic activity and proliferation. It utilizes the yellow tetrazolium salt MTT, which is reduced by metabolically active cells to form purple formazan crystals. The amount of formazan produced is directly proportional to the number of living cells in the sample, providing a quantitative assessment of cell viability and proliferation.

Automatically generated - may contain errors

16 protocols using mtt proliferation assay

1

Anchorage-independent Growth Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To allow for anchorage-independent growth, cells were resuspended in 1% methyl cellulose-containing media and were plated onto Poly (2-hydroxyethyl methacrylate) (Poly-HEMA) (Sigma-Aldrich, USA) coated 96-well plates. The number of colonies formed at various time points post plating were measured using the MTT reagent (according to the manufacturer’s instructions; Sigma-Aldrich, USA).
Adherent growth as a result of Kpnβ1 overexpression was determined using the MTT proliferation assay (according to the manufacturer’s instructions; Sigma-Aldrich, USA).
For the analysis of the effect of p53 and p21 inhibition on Cisplatin-induced cell death, cells were either co-treated with Pifithrin α (Sigma) and Cisplatin, or transfected with control or p21 siRNA (Santa Cruz Biotechnology), using Transfectin (BioRad, USA) transfection reagent, and treated with Cisplatin 48 h post-transfection. MTT assays were performed 24 h after Cisplatin treatment.
+ Open protocol
+ Expand
2

Cell Proliferation Assay of PEG-NHS-Fgn Hydrogels

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess cell proliferation behavior, an MTT proliferation assay (Sigma Aldrich) was used with extracts from 3.6 wt% PEG-NHS-Fgn-R2-SNAP hydrogel composites and PEG-NHS-Fgn controls incubated for 24 hours in DMEM at culture conditions. The MTT Cell Proliferation Assay measures the cell proliferation rate, when changes in cellular metabolism lead to apoptosis or necrosis, this results in a reduction in cell viability. L929 fibroblasts were seeded with conditioned media containing 100uL of extracts in 96-well plates at a density of 1× 104 cells/well. Cells cultured in DMEM served as controls. After 24 hours, the media from each well was replaced with 50uL of MTT solution (1 mg/mL in PBS) and plates were incubated for an additional 2 hours. The MTT solution was exchanged for 100uL isopropanol/well and the absorbance of each well was measured at 570 nm (reference 650 nm) using a Synergy HT Multi-Mode Microplate Reader (BioTek, USA). The relative cell viability was determined as follows (Equation 5):
% cell viability= Abshydrogel  Abscontrol ×100
where Abshydrogel and Abscontrol are the absorbance for cells cultured in hydrogel media extracts and standard media, respectively. Four independent cultures were prepared for hydrogel composites and control hydrogels. Samples with relative cell viabilities greater than 70% were considered non-cytotoxic.
+ Open protocol
+ Expand
3

MTT Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured with the use of 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyl tetrazolium bromide (MTT) proliferation assay (Sigma, St Louis, MO). Briefly, cells were seeded in 96‐well plates and cultured. Cell viability was examined following the standard procedures. Experiments were done in triplicate.
+ Open protocol
+ Expand
4

Exosome-Induced Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTT proliferation assay (Sigma) was performed according to the manufacturer's protocol. A total of 10 µg exosomes was used for each group according to the experimental design. Viability was measured at different time points from 12 h to 72 h after treatment.
+ Open protocol
+ Expand
5

CLA Cytotoxicity and Antiproliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the cytotoxic and antiproliferative effect of c9, t11 CLA on examined cell lines we used MTT proliferation assay (Sigma Aldrich, St. Louis, USA). Cells were cultured in DMEM/F12 (Beas-2B) or RPMI 1640 (A549, Calu-1) medium enriched with 10% FBS for 24 h and then seeded into 96-well plates at the density of 3.5 × 103 (A549 and Beas-2B) and 7.0 × 103 (Calu-1) cells per well. Next, cells were incubated in the presence of different doses of CLA (25 μM, 50 μM, 75 μM for Beas-2B and Calu-1; 50 μM, 100 μM, 200 μM for A549) for 24, 48 and 72 h. After the incubation period, all media were removed and replaced by 200 μl of 10% MTT solution (5 mg of MTT substrate per 1 ml of PBS) in FBS-free cell culture medium and left for 4 h in the incubator. After this time MTT mixture was carefully discarded and newly formatted formazan crystals were dissolved by adding 50 μl of DMSO into each well. The absorbance was measured by Epoch Plate Spectrophotometer (BioTek, Vinooski,VT, USA). Each experiment was performed in 8 biological repeats for each CLA concentration and included 8 vehicle controls (with DMSO).
+ Open protocol
+ Expand
6

MTT Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cellular viability was measured using the MTT proliferation assay (Sigma) according to the manufacture’s protocol. In brief, 1000 cells were seeded in 96-well plates and cultured/treated for 24 h. Viability was measured at different time points from 12 h to 72 h after post-treatment on the basis of experimental requirement.
+ Open protocol
+ Expand
7

Cell Proliferation on PLA Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the ability of HeLa cells to grow on PLA scaffolds with or without Rho1%-PAM coating, a MTT proliferation assay (Sigma Aldrich, Milan, Italy) was performed. After 24, 48 and 72 h from cell seeding, the amount of cells on both type of PLA scaffolds (coated and uncoated) was measured (Fig. 5). PLA scaffolds were washed with PBS and incubated with MTT solution (5 mg/ml). After 3 h, the medium was removed and the obtained formazan crystals were dissolved in 200 µl of pure dimethyl sulfoxide (DMSO). The absorbance (570 nm) of formazan crystals was measured by an ELISA plate reader (Benchmark Plus, BIO-RAD) and background (630 nm) subtracted.
+ Open protocol
+ Expand
8

Cytotoxicity Evaluation of pEGFP-NS3 and HR9 Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MTT proliferation assay (Sigma) was utilized to evaluate the cytotoxicity of the naked DNA (pEGFP-NS3), the HR9/pEGFP-NS3 nanoparticles at different ratios of 1:1, 2:1, 5:1 and 10:1, and various molar concentrations of HR9 peptide (1, 2, 5 and 10) as well as 70% ethanol as a positive control in the non-malignant HEK-293T cell line. MTT assay was done in triplicate according to the manufacturer’s instructions.
+ Open protocol
+ Expand
9

MTT Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured with the use of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) proliferation assay (Sigma-Aldrich Co.). Briefly, cells were seeded in 96-well plates and cultured. Cell viability was examined following standard procedures. Experiments were done in triplicate.
+ Open protocol
+ Expand
10

HDAC Inhibitor Sensitivity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A375 and HT144 cells were seeded at 10,000 cells/well and 5000 cells/well respectively in triplicate in 96-well plates and treated for 24 h with varying concentrations of Butyrate, TSA, Valproic acid and Vorinostat (Fig. 1). After 24 h, relative viable cell numbers were determined using the MTT viability Assay (Sigma), which measures bioreduction of MTT into a soluble formazan that was measured in a microplate reader at A540 nm.

HDAC inhibitor sensitivity assay. The number of viable A375 cells (upper panel) was reduced by Butyrate 2 mM (by 3 %), TSA 100 nM (by 10 %), Valproic acid 1 mM (by 15 %) and Vorinostat 3 μM (by 10 %) compared with the untreated control (set at 100 %). HT-144 cells (lower panel) were more sensitive to HDACi and its viability was reduced by Butyrate 2 mM (by 13 %), TSA 100 nM (by 17 %), Valproic acid 1 mM (by 22 %) and Vorinostat 3 μM (by 25 %). Cell number was determined after 24 h of treatment by the MTT proliferation assay (Sigma). Shown data correspond to representative experiments carried out in triplicate and repeated twice. Values are expressed as the mean ± SD

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!